Durect

About:

DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases, with late-stage development

Website: http://www.durect.com

Top Investors: Oxford Finance LLC

Description:

DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases, with late-stage development programs including REMOXY®, POSIDUR™, ELADUR®, and TRANSDUR®-Sufentanil. DURECT’s proprietary oral, transdermal and injectable depot delivery technologies enable new indications and superior clinical/commercial attributes such as abuse deterrence, improved convenience, compliance, efficacy and safety for small molecule and biologic drugs